Mustang Bio Starts Trading on the NASDAQ

Mustang Bio (NASDAQ:MBIO), a Fortress Biotech (NASDAQ:FBIO) company, began trading its stock on the NASDAQ Global Market.
As quoted in the press release:

Manuel Litchman, M.D., President and Chief Executive Officer of Mustang, said, “Joining the NASDAQ Global Market is a significant milestone for Mustang and our stockholders, and will further establish Mustang in the investment community. We look forward to reporting key milestones in the coming months that may drive substantial value, including initiating construction on a proprietary CAR T manufacturing facility later this year, and reading out Phase 1 data from our lead CAR T therapies MB-101 in glioblastoma and MB-102 in acute myeloid leukemia in early 2018.”

Click here to read the full press release.

Source: globenewswire.com